Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vardit Kram

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2012
Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrualAlon Bajayo, Arik Bar, Adam Denes, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|April 14, 2016
Biglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatinMaja Myren, David J Kirby, Megan L Noonan, et al.
Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
A phase 2 trial of burosumab for treatment of fibroblast growth factor-23 mediated hypophosphatemia in children and adults with fibrous dysplasiaOlivia de Jong, Zubeyir Hasan Gun, Afua Asante-Otoo, et al.
Journal of the American Dental Association (1939)|March 2, 2026
Two cases of tooth resorption in patients receiving denosumab therapyEmily Y Chu, Eswar Kandaswamy, Vinayak Joshi, et al.
Frontiers in Physiology|March 6, 2023
Biglycan regulates bone development and regenerationReut Shainer, Vardit Kram, Tina M Kilts, et al.
Bone Research|April 26, 2026
A phase 2 trial of burosumab for treatment of fibroblast growth factor-23-mediated hypophosphatemia in children and adults with fibrous dysplasiaOlivia de Jong, Zubeyir Hasan Gun, Afua Asante-Otoo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
Peripheral cannabinoid receptor, CB2, regulates bone massOrr Ofek, Meliha Karsak, Nathalie Leclerc, et al.
Scientific Reports|August 15, 2020
Collagen VIα2 chain deficiency causes trabecular bone loss by potentially promoting osteoclast differentiation through enhanced TNFα signalingHai T Pham, Vardit Kram, Qurratul-Ain Dar, et al.
American Journal of Human Genetics|August 23, 2025
Single-cell analysis of human fibrous dysplasia bone reveals a fibrotic transcriptome and GNAS variants in endothelial, perivascular, and stromal cellsKelly L Wentworth, Fernando A Fierro, Tania A Moody, et al.
Bone|January 14, 2026
Gα<sub>s</sub> variant detection discerns skeletal cell types involved in fibrous dysplasia pathogenesisZachary Michel, Vivian MacDonald, Aleena Arif, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2012
Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrualAlon Bajayo, Arik Bar, Adam Denes, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|April 14, 2016
Biglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatinMaja Myren, David J Kirby, Megan L Noonan, et al.
Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
A phase 2 trial of burosumab for treatment of fibroblast growth factor-23 mediated hypophosphatemia in children and adults with fibrous dysplasiaOlivia de Jong, Zubeyir Hasan Gun, Afua Asante-Otoo, et al.
Journal of the American Dental Association (1939)|March 2, 2026
Two cases of tooth resorption in patients receiving denosumab therapyEmily Y Chu, Eswar Kandaswamy, Vinayak Joshi, et al.
Frontiers in Physiology|March 6, 2023
Biglycan regulates bone development and regenerationReut Shainer, Vardit Kram, Tina M Kilts, et al.
Bone Research|April 26, 2026
A phase 2 trial of burosumab for treatment of fibroblast growth factor-23-mediated hypophosphatemia in children and adults with fibrous dysplasiaOlivia de Jong, Zubeyir Hasan Gun, Afua Asante-Otoo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
Peripheral cannabinoid receptor, CB2, regulates bone massOrr Ofek, Meliha Karsak, Nathalie Leclerc, et al.
Scientific Reports|August 15, 2020
Collagen VIα2 chain deficiency causes trabecular bone loss by potentially promoting osteoclast differentiation through enhanced TNFα signalingHai T Pham, Vardit Kram, Qurratul-Ain Dar, et al.
American Journal of Human Genetics|August 23, 2025
Single-cell analysis of human fibrous dysplasia bone reveals a fibrotic transcriptome and GNAS variants in endothelial, perivascular, and stromal cellsKelly L Wentworth, Fernando A Fierro, Tania A Moody, et al.
Bone|January 14, 2026
Gα<sub>s</sub> variant detection discerns skeletal cell types involved in fibrous dysplasia pathogenesisZachary Michel, Vivian MacDonald, Aleena Arif, et al.
Pageof 3